Asan Medical Center
Clinical trials sponsored by Asan Medical Center, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug aims to shrink GI cancers before surgery Results expected Sep 2026 (estimated)
- Iron infusion trial aims to boost energy in stomach cancer patients Results expected Nov 2026 (estimated)
- New hope for rare stomach cancer: chemo drug shows promise in early trial Results expected Dec 2026 (estimated)
- Diabetes Patients' heart arteries under the scanner: new study tracks silent changes Results expected Dec 2026 (estimated)
- Can a phone app help ICU patients recover faster? Results expected Dec 2026 (estimated)
-
Can a blood test guide better cancer treatment after surgery?
Disease control Not yet recruitingThis Phase 3 trial tests whether using a blood test that detects tumor DNA can guide who needs extra therapy after esophageal cancer surgery. Participants will either receive a combination of immunotherapy (tislelizumab), chemotherapy, and radiation, or be monitored without addit…
Phase 3 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for liver cancer patients when immunotherapy stops working
Disease control Not yet recruitingThis phase 2 trial tests two oral drugs, lenvatinib and regorafenib, in 146 adults with advanced liver cancer that cannot be surgically removed and has worsened after initial immunotherapy. The study has two parts: one for patients with better liver function and one for those wit…
Phase 2 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can surgery buy more time for ovarian cancer patients?
Disease control Not yet recruitingThis study looks at whether a second surgery to remove visible tumors (secondary cytoreductive surgery) after chemotherapy helps women with platinum-sensitive recurrent ovarian cancer. About 160 participants will be randomly assigned to get surgery plus chemo or chemo alone. The …
Phase 2 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Can a simple gas help fragile newborns breathe easier?
Disease control Not yet recruitingThis study looks at whether inhaled nitric oxide can help newborns with a hole in their diaphragm (congenital diaphragmatic hernia) who also have high blood pressure in their lungs. About 40 babies will receive the gas, and doctors will check if their oxygen levels improve within…
Phase 4 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Blood test may spot ovarian cancer return months before scans
Diagnosis Not yet recruitingThis study looks at whether a specialized blood test can detect tiny bits of cancer DNA in the blood of women with advanced ovarian cancer after they finish initial treatment. Researchers will follow 300 women for up to 3 years, taking blood samples at key times. The goal is to s…
Sponsor: Asan Medical Center • Aim: Diagnosis
Last updated Jun 28, 2026 00:00 UTC
-
A daily pill that may shield stroke patients from stomach bleeding while on blood thinners
Prevention Not yet recruitingThis phase 3 trial tests whether zastaprazan, a stomach-acid-blocking drug, can prevent upper gastrointestinal bleeding in adults who have recently had a transient ischemic attack (TIA) or ischemic stroke and are taking antiplatelet or anticoagulant medications. Participants take…
Phase 3 • Sponsor: Asan Medical Center • Aim: Prevention
Last updated Jul 30, 2026 00:00 UTC
-
Blood test may spot cancer recurrence months before scans
Knowledge-focused Not yet recruitingThis study is testing a new blood test that looks for tiny bits of cancer DNA (called minimal residual disease or MRD) in patients with endometrial or cervical cancer. The goal is to see if this test can find cancer coming back earlier than standard scans or exams. About 600 part…
Sponsor: Asan Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC